Dimensional Fund Advisors LP Abeona Therapeutics Inc. Transaction History

Dimensional Fund Advisors LP

  • $376 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
SELL
$2.98 - $4.43 $5,349 - $7,951
-1,795 Reduced 13.82%
11,196 $47,000
Q1 2023

May 12, 2023
SELL
$2.25 - $3.27 $12,033 - $17,487
-5,348 Reduced 29.16%
12,991 $36,000
Q4 2022

Feb 09, 2023
SELL
$2.4 - $5.65 $37,545 - $88,388
-15,644 Reduced 46.03%
18,339 $56,000
Q3 2022

Nov 10, 2022
BUY
$2.79 - $5.56 $94,812 - $188,945
33,983 New
33,983 $103,000

Others Institutions Holding ABEO

# of Institutions
57
Shares Held
28.4M
Call Options Held
827K
Put Options Held
44.5K
View Full List

About ABEONA THERAPEUTICS INC.

ABEO Quotes by TradingView
  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $35M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email